Corona Virus Vaccine Market Industry Share, By Application, End-Use, Regional Outlook & Forecast up to 2027
The coronavirus disease (COVID-19) pandemic is the most recent outbreak, which was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared coronavirus disease (COVID-19) as a pandemic on March 11, 2020. COVID-19 is a viral infection caused by a coronavirus called SARS-CoV-2, which affects the respiratory tract. The COVID-19 virus is highly contagious and can be transmitted through direct contact with the infected person or an indirect contact with surfaces in the immediate environment. Moreover, the number of people getting infected by COVID-19 has dynamically increased, making it a global pandemic. For instance, according to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 57.8 million cases and 1.3 million deaths due to coronavirus disease (COVID-19) were reported up till November 22, 2020 across the globe.
Major players operating in the global Corona Virus Vaccine Market include AstraZeneca plc, Pfizer Inc., Sanofi S.A., Novavax, Inc., Moderna, Inc., Sinovac Biotech Ltd., Bharat Biotech International Limited, Johnson & Johnson, BioNTech SE, Serum Institute of India, Shanghai Fosun Pharmaceutical Group Co., Ltd., CanSino Biologics Inc., CureVac AG, Cadila Healthcare Limited, Arcturus Therapeutics Holdings Inc., Entos Pharmaceuticals, and Symvivo.
Comments
Post a Comment